SCHEMBL2535566

SCHEMBL2535566

COC(=O)c1ccc2c(c1)CC(C)(C)C(c1ccc(NC(=O)c3ccccn3)cc1)N2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 2/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
PKM P14618 2/20 0.44
MAPT P10636 1/20 0.44
GRM1 Q13255 2/20 0.43
PTPN1 P18031 1/20 0.42
KDM4E B2RXH2 3/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GRM4 Q14833 9/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MITF O75030 1/20 0.41
KDM6B O15054 1/20 0.40
MAOB P27338 1/20 0.40
KDM5C P41229 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
KDM2A Q9Y2K7 1/20 0.40
KDM3A Q9Y4C1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2529416 0.91 GRM1 (0.44) AURKBSMN1; SMN2NPC1RAB9APKM
SCHEMBL2535710 0.88 PTPN1 (0.49) SMN1; SMN2NPC1RAB9APKMMAPT
SCHEMBL2527678 0.87 GRM4 (0.39) SMN1; SMN2NPC1RAB9AMAPTKDM4E
SCHEMBL2534274 0.86 NPC1 (0.40) AURKBSMN1; SMN2NPC1RAB9APKM
SCHEMBL15509785 0.85 NPC1 (0.46) AURKBSMN1; SMN2NPC1RAB9APKM
SCHEMBL2572744 0.84 ITGB3 (0.40) SMN1; SMN2NPC1RAB9AKDM4EMEN1
SCHEMBL2530882 0.83 NPC1 (0.53) SMN1; SMN2NPC1RAB9AMAPTPTPN1
SCHEMBL2575481 0.83 CRBN (0.45) SMN1; SMN2NPC1RAB9AMAPTKDM4E
SCHEMBL2527675 0.82 KCNK3 (0.47) SMN1; SMN2NPC1RAB9AGRM1GRM4
SCHEMBL2529286 0.81 ALDH1A1 (0.41) SMN1; SMN2NPC1RAB9AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 AURKB 3171/4885SMN1; SMN2 1856/4885NPC1 429/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 AURKB 3171/4885SMN1; SMN2 1856/4885NPC1 429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.